DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022" report to their offering.
Over 50 Million Suffer from Fungal Nail Infections
Fungal nail infections pose a global health threat, with over 50 million people suffering from the contagious condition last year, states a new report by research and consulting firm The authors.
The new report* predicts that prevalent cases of dermatophytic onychomycosis (DO) across US, France, Germany, Italy, Spain, UK, and Japan will increase by a further 15% over the next decade, from 51.50 million cases in 2012 to 59.17 million cases by 2022.
The authors epidemiologists forecast that the US alone will see prevalent cases of DO rise from 31.66 million cases in 2012 to 37.69 million cases by 2022, following a 19.1% increase over the next decade.
The prevalence of DO in the general population across the US, France, Germany, Italy, Spain, and the UK currently ranges from between 2% and 12%.
DO is a fungal infection of the nail fold or nail plate, beginning as a white or yellow spot under the tip of the nail, with discoloration and thickening of the nail worsening as the infection spreads deeper, resulting in nail disfigurement and discomfort. DO accounts for around half of all nail diseases in the world, and represents a considerable medical burden. The disease is not life-threatening, but can cause significant pain and discomfort, and the indolent nature of the disease often leads to cases going undiagnosed and untreated for a long period of time, potentially progressing to the point where walking may become difficult or painful.
The contagious nature of this condition means that DO is often contracted through contact with a contaminated surface. Fungal spores shed by infected individuals are commonly found on household floors, public swimming pools, and gym and sports changing facilities. For this reason, members of the same household have a greater risk of contracting the infection, and Japan's high forecast for DO prevalence could be attributed to the country's traditional practice of walking barefoot in the house, as this practice facilitates spread of DO infection.
- The Dermatophytic Onychomycosis (DO) EpiCast Report provides an overview of the risk factors and global trends of DO in the seven major markets (US, France, Germany, Italy, Spain, UK, and Japan).
- It also includes a 10-year epidemiology forecast of the prevalent cases of DO, segmented by sex, and age (15-29 years, 30-49 years, 50-69 years, and >70 years) in these markets.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving the global DO market.
- Quantify patient populations in the global DO market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DO therapeutics in each of the markets covered.
Key Topics Covered:
1 Tables & Figures
3.1 Risk Factors and Comorbidities
- 3.1.1 Poor peripheral circulation is greater in older men
- 3.1.2 Household contact with other DO patients increases risk of infection 2.5 times
- 3.1.3 Immunosuppression increases susceptibility to DO infections
- 3.1.4 Prevalence of dermatophytic onychomycosis is higher in diabetics than in non-diabetics
3.2 Global Trends
3.3 Forecast Methodology
3.4 Epidemiology Forecast (2012-2022)
- 3.4.1 Prevalent Cases of Dermatophytic Onychomycosis
- 3.4.2 Age-Specific Prevalent Cases of Dermatophytic Onychomycosis
- 3.4.3 Sex-Specific Prevalent Cases of Dermatophytic Onychomycosis
- 3.4.4 Age-Standardized Prevalence of Dermatophytic Onychomycosis
For more information visit Research and Markets